Skip to content

Clinical trials

Observational Lung Diseases, Interstitial trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Observational Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20151
20164
20181
20211
20232
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Unknown status7
Completed3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital3
Guangzhou Institute of Respiratory Disease2
China-Japan Friendship Hospital1
ChromX Health1
Dai Huaping1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Henan University of Traditional Chinese Medicine1
Peking University People's Hospital1
Qianfoshan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial20
Pulmonary Disease, Chronic Obstructive3
Asthma2
Bronchiectasis2
Disease2
Lung Neoplasms2
Pulmonary Fibrosis2
Sjogren's Syndrome2
Tuberculosis, Pulmonary2
Airway Obstruction1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.